Brainsway (BWAY) Long-Term Investments (2018 - 2025)
Brainsway (BWAY) posted quarterly Long-Term Investments of $14.7 million for Q4 2025, up 168.47% on a QoQ basis from $5.5 million in Q2 2025.
Brainsway (BWAY) Long-Term Investments (2018 - 2025) Analysis & Trends
Brainsway (BWAY) has reported Long-Term Investments for 3 consecutive years, with $14.7 million the latest figure, recorded in Q4 2025.
- Quarterly Long-Term Investments changed N/A year-over-year to $14.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $14.7 million (changed N/A YoY) and the FY2025 annual result came in at $14.7 million, changed N/A from the prior year.
- Long-Term Investments rose to $14.7 million in Q4 2025 per BWAY's latest filing, from $5.5 million in the prior quarter.
- Over the last five years, Long-Term Investments for BWAY reached as high as $14.7 million in Q4 2025 and fell as low as $5.5 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.09 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 285.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 166.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 121.00 Mn |
| 10 | Brainsway | 646.63 Mn | 587.74 Mn | 11.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14.66 Mn |
| Jun 30, 2025 | 5.46 Mn |
| Mar 31, 2019 | 1.01 Mn |
| Dec 31, 2018 | 1.01 Mn |
| Sep 30, 2018 | 1.02 Mn |
| Jun 30, 2018 | 1.01 Mn |